Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Porcine
50%
Central Nervous System
50%
Pharmacokinetic Model
50%
Clinical Features
50%
Meta-analysis
50%
Brain Abscess
50%
Clinical Outcomes
50%
Acyclovir
50%
95% Confidence Interval
50%
Inhibitory Concentration 50
25%
Extracellular Fluid Compartment
14%
Cerebrospinal Fluid
12%
Herpes Simplex Virus Encephalitis
12%
Third Dose
12%
Area under the Curve
12%
Extracellular Fluid
12%
Fatality
9%
Microdialysis
6%
Fluid Compartments
6%
Cisternal
6%
Second Dose
6%
Central Nervous System Penetration
6%
Ventricular Cerebrospinal Fluid
6%
Severe Infection
6%
Prolonged Infusion
6%
Pharmacokinetic Parameters
6%
Penetration Ratio
6%
Target Concentration
6%
Neurological Sequelae
6%
First Dose
6%
Peak Concentration
6%
Initial Dose
6%
Fluid-filled
6%
Dosing Regimen
6%
Herpes Simplex Virus Type 1 (HSV-1)
6%
High Mortality
6%
Inflammatory Conditions
6%
Veterinary Science and Veterinary Medicine
Central Nervous System
100%
Cerebrospinal Fluid
54%
Ganciclovir
50%
Aciclovir
50%
Lumbar
21%
Blood Plasma
21%
Cytomegalovirus
21%
Herpes Simplex Virus
19%
Pig
13%
Viral Encephalitis
12%
Otitis Media
10%
Lateral Ventricle
7%
Intravenous Drug Administration
7%
Cisterna Magna
7%
Encephalitis
7%
Inflammation
6%
Infectious Disease
6%
Human Alphaherpesvirus 1
6%
Pharmacology, Toxicology and Pharmaceutical Science
Aciclovir
50%
Clinical Feature
50%
Brain Abscess
50%
Pharmacokinetics
50%
IC50
25%
Case Fatality Rate
20%
Infection
16%
Herpes Simplex Encephalitis
12%
Otitis Media
10%
Sinusitis
10%
Random Effects Model
10%
Diseases
10%
Streptococcus
10%
Immunocompromised Patient
10%
Mastoiditis
10%
Enterobacteriaceae
10%
Staphylococcus
10%
Etiology
10%
Human Alphaherpesvirus 1
6%
Inflammation
6%
Pharmacokinetic Parameter
6%
Sow (Swine)
6%
Microdialysis
6%
